The National Institute of Environmental Health Sciences (NIEHS) awarded a $1,127,150.00 firm-fixed-price purchase order contract to Azenta US Inc., doing business as Brooks Life Sciences Inc., for next-generation DNA and RNA sequencing services. The contract has an ultimate completion date of July 13, 2026. There was no set-aside designation for this requirement, which is aligned with NIEHS' genomic research efforts. Azenta, a subsidiary of Azenta, Inc., is a provider of life sciences products...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Azenta US Inc., doing business as Brooks Life Sciences Inc., for DNA whole exome sequencing services to support new studies under the NCI's Childhood Cancer Data Initiative. The period of performance is from July 27, 2020 to July 26, 2023, with a total ceiling value of $479,145. This contract is part of the NCI Genomic Characterization Centers contract vehicle, a larger indefinite...
This is a $5,762.04 firm fixed price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Azenta US Inc., doing business as Brooks Life Sciences Inc. The contract is for DNA sequencing services and does not have a set-aside designation. Azenta US Inc. is a subsidiary of Azenta, Inc. that specializes in life sciences products and services, including genomic services, cryogenic storage, and laboratory equipment. The company...
This is a $11,448 firm fixed-price purchase order awarded by the U.S. Department of Agriculture's Agricultural Research Service to Azenta US Inc., doing business as Brooks Life Sciences Inc., for RNA sequencing services. The contract has no set-aside designation, indicating Azenta's competitiveness in providing these specialized genomic services to federal agencies. Azenta US Inc. is a subsidiary of the parent company Azenta, Inc., which has an extensive history of providing life sciences...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Azenta US Inc., doing business as Brooks Life Sciences Inc. The contract, valued at $12,513.00, is for genomic DNA re-extraction from frozen stool samples, with an ultimate completion date of May 10, 2024. The contract has no set-aside designation. Azenta is a subsidiary of the parent company Azenta, Inc., which is a...
This contract, awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute, is for the purchase of single cell ribonucleic acid (RNA) sequencing of adaptive immune cells and T and B cell receptor repertoire analysis. The contract has a firm fixed price of $29,666.00 and was awarded on August 5, 2022 to Azenta US Inc., doing business as Brooks Life Sciences Inc. This award does not have a set-aside designation. Azenta US Inc. is a...
This is a $35,280 firm fixed price purchase order awarded by the United States Department of Agriculture (USDA) Agricultural Research Service (ARS) to Azenta US Inc., doing business as Brooks Life Sciences Inc. The contract is for RNA sequencing services, with a period of performance through March 31, 2025. The award resulted from a small business set-aside solicitation for laboratory testing services under NAICS code 541380. As a provider of genomic services, biorepository management, and...
The Department of Health and Human Services National Institutes of Health National Institute of Dental and Craniofacial Research awarded a $25,117.50 firm fixed price purchase order to Azenta US Inc., doing business as Brooks Life Sciences Inc., for RNA sequencing services of neural crest derivatives. This purchase order was issued under Azenta's $10 million single award blanket purchase agreement with NIH's Office of Logistics and Acquisition Operations for biological materials and laboratory...
The National Cancer Institute (NCI) awarded a $35,015,845 definitive, firm-fixed-price contract to Azenta US Inc. (doing business as Brooks Life Sciences Inc.) to support the research molecular characterization goals of the Childhood Cancer Data Initiative (CCDI) and improve diagnosis and treatment for childhood and adolescent and young adult (AYA) cancers. The contract has a period of performance through December 2, 2029. This is a new award without any set-aside designation, indicating...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Azenta US Inc. (doing business as Brooks Life Sciences Inc.) for an annual standard maintenance and support subscription for the LIMFINITY software system. The contract has an ultimate completion date of May 31, 2026 and a ceiling value of $138,743.79. There is no set-aside designation. Azenta US Inc. is a for-profit life sciences organization that provides...